Prime Minister Boris Johnson says the UK will stick to its lockdown easing plan despite concerns over the vaccine supply.
The UK’s medicines regulator says the benefits of the Oxford-AstraZeneca vaccine outweigh any potential side effects.
Official figures show more than half of England’s employees traveled into work last week.
